102 related articles for article (PubMed ID: 21255956)
21. High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus.
Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
J Diabetes Complications; 2015; 29(1):142-5. PubMed ID: 25456820
[TBL] [Abstract][Full Text] [Related]
22. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein A-I and high-density lipoprotein: is this the beginning of the era of noninvasive angioplasty?
Ballantyne CM; Nambi V
J Am Coll Cardiol; 2004 Oct; 44(7):1436-8. PubMed ID: 15464324
[No Abstract] [Full Text] [Related]
24. Lipid parameters in patients with acute coronary syndromes versus stable coronary artery disease.
Vonbank A; Saely CH; Rein P; Drexel H
Eur J Clin Invest; 2015 Oct; 45(10):1092-7. PubMed ID: 26255620
[TBL] [Abstract][Full Text] [Related]
25. [New studies of high dosage statins and fibrates. How is lipid lowering therapy changing? (interview by Dr. med. Dirk Einecke)].
Klose G
MMW Fortschr Med; 2005 Dec; 147(49-50):20. PubMed ID: 16401005
[No Abstract] [Full Text] [Related]
26. Statin prescription strategies and atherogenic cholesterol goals attainment in Lebanese coronary artery disease patients.
Lama S; Souraya D; Youssef F
Int J Clin Pharm; 2017 Aug; 39(4):919-926. PubMed ID: 28523462
[TBL] [Abstract][Full Text] [Related]
27. Changing face of dyslipidemia therapy.
Banerjee AK
Indian Heart J; 2008; 60(3):192-4. PubMed ID: 19240305
[No Abstract] [Full Text] [Related]
28. [Assessment of hypolipidemic efficacy and safety of various doses of atorvastatin].
Kukharchuk VV; Kaminnĭ AI
Kardiologiia; 2007; 47(10):51-3. PubMed ID: 18260944
[No Abstract] [Full Text] [Related]
29. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
30. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Cariolou M; Ganotakis ES; Mikhailidis DP; Elisaf MS
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):211-21. PubMed ID: 17056835
[TBL] [Abstract][Full Text] [Related]
31. Relation of change in apolipoprotein B/apolipoprotein A-I ratio to coronary plaque regression after Pravastatin treatment in patients with coronary artery disease.
Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Matsumoto M; Washio T; Kumabe N; Hirayama A
Am J Cardiol; 2010 Jan; 105(2):144-8. PubMed ID: 20102908
[TBL] [Abstract][Full Text] [Related]
32. Low-density lipoprotein cholesterol-independent effects of statins on coronary artery disease.
Takagi H; Umemoto T
Am J Cardiol; 2011 Jan; 107(2):336. PubMed ID: 21211613
[No Abstract] [Full Text] [Related]
33. Lipid management with statins. The lower the better?
Laufs U; Liao JK; Böhm M
Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study.
Lablanche JM; Leone A; Merkely B; Morais J; Alonso J; Santini M; Eha J; Demil N; Licour M; Tardif JC;
Arch Cardiovasc Dis; 2010 Mar; 103(3):160-9. PubMed ID: 20417447
[TBL] [Abstract][Full Text] [Related]
35. HDL cholesterol, Part II. How to get more of a good thing.
Harv Mens Health Watch; 2007 Sep; 12(2):1-4. PubMed ID: 18217261
[No Abstract] [Full Text] [Related]
36. Cytochrome P450 and atherosclerosis.
Luoma P
Clin Pharmacol Ther; 1996 Apr; 59(4):484. PubMed ID: 8612397
[No Abstract] [Full Text] [Related]
37. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
38. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.
Avellone G; Di Garbo V; Abruzzese G; Campisi D; De Simone R; Raneli G; Licata G
Int Angiol; 2006 Mar; 25(1):26-34. PubMed ID: 16520721
[TBL] [Abstract][Full Text] [Related]
39. Clinical research on serum lipid changes in children with Kawasaki disease and its relationship with coronary artery lesions.
Zhang PP; Li YT; Li XF; Pan L; Chen ZG
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-181. PubMed ID: 25237009
[No Abstract] [Full Text] [Related]
40. [Apolipoprotein A-I can be a new tool in the treatment of atherosclerosis].
Olsson AG
Lakartidningen; 2004 Mar; 101(13):1196-7. PubMed ID: 15101245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
